The weeklong Antibody Therapeutics pipeline reveals the exciting developments in next-generation antibody therapeutics, including Antibody-Drug Conjugates, Bispecific Antibody Therapeutics, and Cancer Immunotherapies. Along with engineering breakthroughs, this pipeline also explores successful R&D strategies, translational case studies, clinical results, and efficacy data for these promising molecules as they seek to conquer cancer and other diseases and promote human health.


January 20-21

Engineering Next-Generation Cancer Immunotherapies

January 21-22

Antibody-Drug Conjugates

January 23-24

Bispecific Antibody Therapeutics


Keynote Speakers

Shahram Salek-Ardakani, PhD, Senior Director, Cancer Immunology Discovery, Pfizer


Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC


Partha S. Chowdhury, Senior Director, Biologics Research, Sanofi Genzyme


* The program is subject to change without notice, due to unforeseen reason.

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2019/11/26
Agenda,Sponsor updated
2019/11/14
Agenda updated
2019/11/06
Sponsor updated
2019/10/15
Speaker,Sponsor updated
2019/09/25
Agenda,Sponsor updated
2019/08/23
Sponsor updated




2020 Conferences & Training Seminars